{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-234001","form_type":"8-K","ticker":"KRRO","cik":"0001703647","company_name":"Korro Bio, Inc.","filed_at":"2025-10-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.202971+00:00","generated_at":"2026-05-17T04:19:32.168116+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Korro Bio CFO resigns; CEO takes interim CFO role","bullets":["CFO Vineet Agarwal resigns effective Oct 17, 2025; will advise for 30 days.","CEO Dr. Ram Aiyar named interim CFO in addition to CEO duties, no extra compensation.","Separation benefits include 9 months base salary ($352,500), prorated FY2025 target bonus ($149,400), and extended option exercise through Mar 31, 2027.","Departure is not related to any disagreement with management."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-234001","json":"https://secwatch.observer/filing/0001193125-25-234001.json","markdown":"https://secwatch.observer/filing/0001193125-25-234001.md","text":"https://secwatch.observer/filing/0001193125-25-234001.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1703647/000119312525234001/0001193125-25-234001-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1703647/000119312525234001/krro-20251007.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:19:32.168116+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}